La Mesa Mobile App Cross Platform Development
BASIC
- Around 5 Screens.
- Around 5 Integrations
- Only simple validations on device
- No-obligation inquiry.
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
STANDARD
- Around 10 Screens
- Around 10 Integrations
- Simple business logic for Validations / Calculations / Chart Data etc.
- Some local storage of data
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
- 1 Project Manager (shared)
- 1 Team Lead (shared)
PREMIUM
- Around 20 Screens
- Around 20 Integrations
- Complex business logic like Interactive Charts, Animations, Validations, Conditions etc.
- Complete local storage of data used by App
- We will create suggestions on monthly basis for improvement for you.
Cross-Platform App Development Services & Solutions in La Mesa
We take your groundwork and create a market-ready app based on your needs while you focus on product and company growth.
Flutter is the fastest-growing cross-platform development framework. It was introduced in 2017 by Google and managed to gain great popularity among cross-platform programmers.
La Mesa News
Disney reaches new deal with YouTube TV, ending dayslong blackout for customers
Disney and YouTube TV reached a new deal to bring channels like ABC and ESPN back to the Google-owned live streaming platform Friday, ending a blackout for customers that dragged on for about two ...
Uwan maintains strength outside PAR; Signal No. 2 raised over 10 areas
Typhoon Uwan maintains its strength, moving northward outside the Philippine Area of Responsibility (PAR) as Signal No. 2 remains over 10 areas, according to the Tropical Cyclone Bulletin posted by ...
This Is What Happens in Your Brain During a Soccer Match
Scientists found that soccer fans’ emotional highs and lows activate specific brain circuits tied to reward and control.
Combination immunotherapy for rare cancers shows improved efficacy and survival rates
New results from a multicenter clinical trial show that combining immunotherapy drugs nivolumab and ipilimumab significantly improves treatment response in patients with advanced and ...